Literature DB >> 12856217

Smallpox vaccination: a review, part I. Background, vaccination technique, normal vaccination and revaccination, and expected normal reactions.

Vincent A Fulginiti1, Arthur Papier, J Michael Lane, John M Neff, D A Henderson.   

Abstract

Because smallpox could be a factor in bioterrorism, the United States has provided guidelines for smallpox vaccination of certain members of the population, including health care workers and first responders, as well as military personnel. A plan for more extensive vaccination, if it is needed in the event of a bioterrorist attack, is being developed under the aegis of the Centers for Disease Control and Prevention. The characteristics of smallpox vaccine, the technique of administration, and the expected reactions to primary vaccination and revaccination are outlined in this article.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12856217     DOI: 10.1086/375824

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  29 in total

1.  Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model.

Authors:  Megan M McCausland; Mohammed Rafii-El-Idrissi Benhnia; Lindsay Crickard; John Laudenslager; Steven W Granger; Tomoyuki Tahara; Ralph Kubo; Lilia Koriazova; Shinichiro Kato; Shane Crotty
Journal:  Antivir Ther       Date:  2010

2.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

3.  Validity of self-assessment of skin reaction after smallpox vaccination.

Authors:  Michael Huerta; Ran D Balicer; Daniel Mimouni; Avi Goldberg; Mda Moshe Furman; Eyal Klement; Ariel Hourvitz; Itamar Grotto
Journal:  Public Health Rep       Date:  2006 Jan-Feb       Impact factor: 2.792

4.  Orthopox Viruses: Infections in Humans.

Authors:  Georg Pauli; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2010-11-17       Impact factor: 3.747

5.  Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax.

Authors:  Michael S Seaman; Marissa B Wilck; Lindsey R Baden; Stephen R Walsh; Lauren E Grandpre; Colleen Devoy; Ayush Giri; Lizanne C Noble; Jane A Kleinjan; Kristen E Stevenson; Haesook T Kim; Raphael Dolin
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

6.  Comparison of methods for detection of vaccinia virus in patient specimens.

Authors:  Daniel P Fedorko; Jeanne C Preuss; Gary A Fahle; Li Li; Steven H Fischer; Patricia Hohman; Jeffrey I Cohen
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

7.  Genomic analysis of vaccine-derived poliovirus strains in stool specimens by combination of full-length PCR and oligonucleotide microarray hybridization.

Authors:  Majid Laassri; Eugenia Dragunsky; Joan Enterline; Tatiana Eremeeva; Olga Ivanova; Kathleen Lottenbach; Robert Belshe; Konstantin Chumakov
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

8.  Protective murine and human monoclonal antibodies against eczema vaccinatum.

Authors:  Yoshiaki Tomimori; Yuko Kawakami; Megan M McCausland; Tomoaki Ando; Lilia Koriazova; Shinichiro Kato; Toshiaki Kawakami; Shane Crotty
Journal:  Antivir Ther       Date:  2011

9.  Characterization and use of mammalian-expressed vaccinia virus extracellular membrane proteins for quantification of the humoral immune response to smallpox vaccines.

Authors:  Alonzo D García; Clement A Meseda; Anne E Mayer; Arunima Kumar; Michael Merchlinsky; Jerry P Weir
Journal:  Clin Vaccine Immunol       Date:  2007-06-27

10.  Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization.

Authors:  Kaori Shinoda; Linda S Wyatt; Kari R Irvine; Bernard Moss
Journal:  Virol J       Date:  2009-03-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.